Orthopedic Digit Implants Market Size
Orthopedic Digit Implants Market size was valued at around USD 387.2 million in 2022 and is estimated to grow at over 6.2% CAGR between 2023 and 2032. The increasing prevalence of orthopedic diseases, surging preference for minimally invasive surgeries, and technological advancements in orthopedic digit implants are some of the key factors driving the market growth.
The rising incidence of orthopedic diseases, such as osteoarthritis, rheumatoid arthritis, and traumatic injuries, has spurred an increased demand. These health conditions often require the use of orthopedic digit implants to provide support, stability, and assistance in managing functional limitations associated with various orthopedic conditions. According to the World Health Organization, in 2019, approximately 528 million people worldwide were living with osteoarthritis, marking a 113% increase since 1990.
The significant and escalating number of individuals living with various orthopedic conditions, resulting in functional limitations, is attributed to rapid population growth and an increase in the aging population. Consequently, the substantial disease burden and the high prevalence of related disorders are expected to propel the growth of the market in the near future.
Orthopedic digit implants refer to specialized orthopedic devices or prosthetics component designed to address various orthopedic conditions affecting the fingers and toes. These implants are specifically crafted to provide support, stability, and functional assistance to individuals experiencing musculoskeletal discomfort, deformities, or limitations in their digital joints.
Orthopedic Digit Implants Market Report Attributes
Report Attribute |
Details |
Base Year: | 2022 |
---|
Orthopedic Digit Implants Market Size in 2022: | USD 387.2 Million |
---|
Forecast Period: | 2023 to 2032 |
---|
Forecast Period 2023 to 2032 CAGR: | 6.2% |
---|
2032 Value Projection: | USD 695.5 Million |
---|
Historical Data for: | 2018 to 2022 |
---|
No. of Pages: | 160 |
---|
Tables, Charts & Figures: | 217 |
Segments covered: | Product Type, Material, End-use, and Region |
---|
Growth Drivers: | - Increasing prevalence of orthopedic diseases
- Technological advancements
- Surging preference for minimally invasive surgeries
|
---|
Pitfalls & Challenges: | - Post-surgery complications
|
---|
The post-surgery complications related to orthopedic digit implant procedures may impact both patient outcomes and market dynamics. Complications such as infections, implant rejection, malalignment, limited range of motion, and issues related to implant durability can hinder the intended benefits of these innovative solutions designed to enhance digit functionality post-amputation.
COVID-19 Impact
The emergence of the COVID-19 pandemic marked an unparalleled occurrence that significantly affected public health, resulting in a sharp increase in hospitalizations. The pandemic had adverse effects on the healthcare system, necessitating the widespread reassignment of healthcare personnel. Consequently, this resulted in the postponement of diagnosis and treatment of orthopedic disorders and other related conditions as these procedures require close contact with the patients that may increase the risk of infection to practitioners and other patients. As a result, the market experienced a decline in growth throughout 2020.
Orthopedic Digit Implants Market Trends
Rising advancements in orthopedic digit implants intended to improve the functionality, durability, and overall performance to better meet the needs of individuals who have undergone digit amputations will spur the business growth.
- The development of advanced biomaterials with improved biocompatibility and durability has significantly enhanced the built quality of these implants. These materials include alloys, ceramics, and biopolymers coatings that mimic natural bone and joint properties, promoting better integration with the surrounding tissues.
- Moreover, biomechanics studies and computer-aided design (CAD) have contributed to precise implant designs that closely mimic natural joint movements, reducing complications. Additionally, minimally invasive surgical techniques, coupled with advancements in surgical navigation systems and robotics, enhance precision and minimize postoperative challenges.
- Furthermore, the incorporation of smart implants and sensors have enabled real-time monitoring, providing valuable data on joint performance and healing progress. Biological coatings and surface modifications have also contributed to improved integration and faster bone healing.
- These advancements not only improve patient outcomes but also contribute to the dynamic market requirements. Continued research and innovation in these areas are anticipated to shape the orthopedic digit implants industry.
Orthopedic Digit Implants Market Analysis
Based on product type, the market is segmented into metatarsal joint implants, metacarpal joint implants, hemi phalangeal implants, scaphoid bone implants, and toe intramedullary implants. The metatarsal joint implants segment was valued at around USD 387.2 million in 2022 and is expected to exhibit a robust growth trend throughout the analysis period.
- The metatarsophalangeal joints are susceptible to various disorders, including arthritis, deformities, and traumatic injuries. According to a report published by Medscape, in 2023, metatarsal fractures make up 5%-6% of all fractures and account for about 35% of all foot fractures in adults and 61% of all foot fractures in children. Metatarsal joint implants address these conditions, contributing to their high demand and dominant market share.
- Moreover, the adoption of minimally invasive surgical techniques for metatarsal joint implantation has become a prevailing trend. This shift has led to reduced recovery times and improved patient outcomes, aligning with the growing demand for streamlined and effective orthopedic solutions. Thus, these factors are anticipated to play a crucial role in propelling the future market expansion of orthopedic digit implants.
Based on material, the orthopedic digit implants market is segmented as titanium, nitinol, silicon pyrocarbon, and others. The titanium segment held the largest revenue share in 2022 and was valued at USD 159.8 million and is projected to expand at a CAGR of 6.2% during the forecast period to reach a market value of USD 288.5 million by 2032.
- Titanium exhibits excellent biocompatibility, making it well-tolerated by the human body. This characteristic reduces the risk of adverse reactions and implant rejections. Additionally, titanium's corrosion resistance ensures the longevity of implants, contributing to their durability and overall effectiveness.
- Moreover, titanium implants facilitate osseointegration, a crucial process where the implant fuses with the surrounding bone tissue. This enhances the stability of the implant and promotes long-term success.
- Furthermore, the durability of titanium implants ensures their long-term functionality. Orthopedic digit implants, particularly those made from titanium, can withstand the mechanical stresses associated with joint movement, providing sustained support and longevity for patients.
Based on end-use, the orthopedic digit implants market is segmented into hospitals and orthopedic clinics. The hospitals segment held a significant share in 2022 and is projected to reach more than USD 490.3 million by 2032.
- Hospitals, with their comprehensive healthcare infrastructure, specialized orthopedic departments, and skilled medical professionals, serve as primary centers for orthopedic surgeries, including digit implantation. Specialized orthopedic departments in hospitals are equipped with specialized facilities and experienced orthopedic surgeons. These departments are well-suited to handle complex orthopedic procedures, including digit implant surgeries.
- Moreover, the extensive healthcare infrastructure of hospitals ensures that they can provide a wide range of services related to orthopedic digit implants. This includes pre-surgical assessments, state-of-the-art operating rooms, and post-operative care, contributing to a seamless patient experience. Thus, specialized departments, comprehensive infrastructure, and accessibility will fuel the segmental growth.
The U.S. dominated the North America orthopedic digit implants market with a significant market share in 2022 and is anticipated to expand at a notable pace to reach more than USD 285 million by 2032.
- This notable market share can be attributed to various factors, including the presence of leading industry players, increasing demand for orthopedic digit implants, and rising incidence of orthopedic diseases, among other key drivers.
- These leading industry players in the U.S. invest in research and development focusing on advanced orthopedic digit implants contributing to market growth. Innovations in the design and functionality of these devices are aimed at improving patient comfort and effectiveness in managing orthopedic conditions.
- Moreover, as the population ages, the incidence of musculoskeletal problems, such as osteoarthritis, arthritis, and joint injuries, has been on the rise in the country. This has led to a higher demand for orthopedic digit implants.
- Furthermore, medical insurance-providing companies such as Medicare and Medicaid in developed countries including the U.S. have focused their efforts on developing reimbursement for the population suffering from orthopedic diseases. Such a favorable scenario for better patient care and management proves beneficial for the overall business progression.
Orthopedic Digit Implants Market Share
The orthopedic digit implants industry is consolidated in nature, with companies competing to offer superior orthopedic digit implants in this business space. Prominent players such as Smith & Nephew, Stryker Corporation, and Johnson & Johnson hold a significant share in this market. These companies are diligently directing their efforts towards continuous type innovation to gain substantial market share.
Orthopedic Digit Implants Market Companies
Some of the eminent market participants operating in the orthopedic digit implants industry include:
- Smith & Nephew
- Stryker Corporation
- Johnson & Johnson
- Arthrex GmbH
- Merete GmbH
- Acumed LLC
- Vilex, LLC
- Zimmer Biomet
- Wright Medical
- Anika Therapeutics, Inc.
Orthopedic Digit Implants Industry News:
- In September 2023, Stryker launched minimally invasive surgical bunion treatment. The new technology features MIS joint preparation, triplanar reduction and a three-screw construct that creates a tension band for biomechanical stability. This product launch may help the company to enhance its product portfolio and business revenue.
- In January 2021, Smith & Nephew announced that it had completed the acquisition of the Extremity Orthopedics business from Integra LifeSciences Holdings Corporation. This acquisition helped the company to strengthen its orthopedic business segment.
Orthopedic digit implants market research report includes an in-depth coverage of the industry with estimates & forecasts in terms of revenue in USD (million) from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Product Type, 2018 - 2032 (USD Million)
- Metacarpal joint implants
- Metatarsal joint implants
- Hemi phalangeal implants
- Scaphoid bone implants
- Toe intramedullary implants
By Material, 2018 - 2032 (USD Million)
- Titanium
- Nitinol
- Silicon pyrocarbon
- Other materials
By end-use, 2018 - 2032 (USD Million)
- Hospitals
- Orthopedic clinics
The above information is provided for the following regions and countries:
- North America
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA